跳至主要内容
临床试验/NCT02483351
NCT02483351已完成2 期

Aneurysmal Subarachnoid Hemorrhage: Red Blood Cell Transfusion and Outcome - A Pilot Randomized Controlled Trial

Ottawa Hospital Research Institute4 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2015年10月最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
入组人数
60
试验地点
4
主要终点
Randomization Rate

研究概览

简要总结

The purpose of this study is to determine the feasibility of conducting a large trial examining the effect on clinical outcome of a liberal red blood cell (RBC) transfusion strategy compared to a restrictive strategy (usual care) in patients with aneurysmal subarachnoid hemorrhage (SAH).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥18 years old at time of presentation
  • First ever episode aneurysmal SAH
  • Confirmed aneurysmal SAH diagnosis: as confirmed by treating Neurosurgeon or Neuro-interventionalist and supported by blood in subarachnoid space (demonstrated on cranial imaging or cerebrospinal fluid positive for xanthochromia) that is the result of a ruptured saccular aneurysm (confirmed by cranial imaging - cranial topography or magnetic resonance imaging angiography or catheter angiogram)
  • Incident hemoglobin ≤100g/L within 14 days following SAH (defined by first day of hospital presentation)

排除标准

  • Physician and or family decision to withdraw/withhold critical care at time of enrolment
  • Active bleeding with hemodynamic instability at time of enrolment
  • Patients with contra-indication or known objection to blood transfusions
  • SAH due to causes other than saccular aneurysm rupture including mycotic, traumatic and dissecting aneurysms, and aneurysms associated with arteriovenous malformations.

研究组 & 干预措施

Restrictive RBC Transfusion Strategy

Active Comparator

干预措施: Restrictive Red Blood Cell Transfusion Strategy (Other)

Liberal RBC Transfusion Strategy

Experimental

干预措施: Liberal Red Blood Cell Transfusion Strategy (Other)

结局指标

主要结局

Randomization Rate

时间窗: 12 months

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Shane English

Associate Scientist

Ottawa Hospital Research Institute

研究点 (4)

Loading locations...

相似试验

Aneurysmal Subarachnoid Hemorrhage: Red Blood Cell... | 临床试验